Affiliation:
1. Department of Neurology Ajou University School of Medicine, Ajou University Medical Center Suwon South Korea
2. Department of Radiology Ajou University School of Medicine, Ajou University Medical Center Suwon South Korea
Abstract
Background
Vertebral artery dissections (VADs) may extend from the extracranial to the intracranial vasculature (e+iVAD). We evaluated how the characteristics of e+iVAD differed from those of intracranial VAD (iVAD).
Methods and Results
From 2002 to 2019, among consecutive patients with cervicocephalic dissection, those with iVAD and e+iVAD were included, and their clinical characteristics were compared. In patients with unruptured dissections, a composite clinical outcome of subsequent ischemic events, subsequent hemorrhagic stroke, or mortality was evaluated. High‐resolution magnetic resonance images were analyzed to evaluate intracranial remodeling index. Among 347 patients, 51 (14.7%) had e+iVAD and 296 (85.3%) had iVAD. The hemorrhagic presentation occurred solely in iVAD (0.0% versus 19.3%), whereas e+iVAD exhibited higher ischemic presentation (84.3% versus 27.4%;
P
<0.001). e+iVAD predominantly presented steno‐occlusive morphology (88.2% versus 27.7%) compared with dilatation patterns (11.8% versus 72.3%;
P
<0.001) of iVAD. The ischemic presentation was significantly associated with e+iVAD (iVAD as a reference; adjusted odds ratio, 3.97 [95% CI, 1.67–9.45];
P
=0.002]). Patients with unruptured VAD showed no differences in the rate of composite clinical outcome between the groups (log‐rank,
P
=0.996). e+iVAD had a lower intracranial remodeling index (1.4±0.3 versus 1.6±0.4;
P
<0.032) and a shorter distance from dural entry to the maximal dissecting segment (6.9±8.4 versus 15.7±7.4;
P
<0.001).
Conclusions
e+iVAD is associated with lower rates of hemorrhages and higher rates of ischemia than iVAD at the time of admission. This may be explained by a lower intracranial remodeling index and less deep intrusion of the dissecting segment into the intracranial space.
Publisher
Ovid Technologies (Wolters Kluwer Health)